# The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

Study · id `cardio:ct-nct01410617` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01410617](<https://clinicaltrials.gov/study/NCT01410617>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01410617

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01410617. Randomized; no masking; primary purpose prevention. Start 2011-08 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01410617, source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)
- Start date: 2011-08 (registry gives no type) (ClinicalTrials.gov record NCT01410617, source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)
- Primary completion: 2013-09 (anticipated) (ClinicalTrials.gov record NCT01410617, source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01410617, source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)
- Countries: Iran (ClinicalTrials.gov record NCT01410617, source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01410617-2013-03-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
- Condition: Chronic Kidney Disease stage3
- Condition: Chronic Kidney Disease stage4
- Condition: Coronary Artery Disease
- Intervention (Procedure): hemodialysis
- Lead sponsor: Imam Khomeini Hospital
- Lead sponsor class: OTHER
- Collaborator: Tehran University of Medical Sciences
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Tehran University of Medical Sciences (`cardio:org-tehran-university-of-medical-sciences`)

## Provenance

Content hash: a8b05ca30409c6762d82b46c47352e975311db4e1f1f906e9870c331cfaebac0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
